1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A first-in-human phase 1a/b trial of LY3484356, an oral selective estrogen receptor (ER) degrader (SERD) in ER+ advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC): Results from the EMBER study
    Meeting Abstract

    Jhaveri, K. L.; Lim, E.; Hamilton, E. P.; Saura, C.; Meniawy, T.; Jeselsohn, R.; Beck, J. T.; Kaufman, P. A.; Sammons, S.; Banda, K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib (N+C) versus sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial
    Meeting Abstract

    Apolo, A. B.; Powles, T.; Burotto, M.; Bourlon, M. T.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Copanlisib + rituximab versus rituximab + placebo in patients with relapsed follicular (FL) or marginal zone lymphoma (MZL): Subset analysis from the phase III CHRONOS-3 trial
    Meeting Abstract

    Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yanez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments
    Meeting Abstract

    Ardeshirrouhanifard, S.; Fosså, S.; Huddart, R. A.; Monahan, P. O.; Fung, C.; Song, Y.; Dolan, M. E.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Racial and ethnic disparities among patients with breast cancer and COVID-19
    Meeting Abstract

    Nagaraj, G.; Accordino, M. K.; French, B.; Kuderer, N. M.; Lyman, G. H.; Stover, D. G.; Blinder, V. S.; Schmidt, A. L.; Shatsky, R. A.; Grover, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma
    Meeting Abstract

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) exposed/refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies
    Meeting Abstract

    Rodríguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM)
    Meeting Abstract

    Bahlis, N. J.; Raje, N. S.; Costello, C.; Dholaria, B. R.; Solh, M. M.; Levy, M. Y.; Tomasson, M. H.; Dube, H.; Liu, F.; Liao, K. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM)
    Meeting Abstract

    Carvajal, R. D.; Sato, T.; Butler, M. O.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L. F.; Rioth, M.; Hamid, O.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion+ non-small-cell lung cancer (NSCLC)
    Meeting Abstract

    Drilon, A. E.; Gautschi, O.; Besse, B.; Subbiah, V.; Tan, D. S. W.; Park, K.; De Braud, F. G.; Alonso, G.; Wolf, J.; Soldatenkova, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save